Catalyst Wire Dossier Catalyst Wire Dossier

Levocetirizine (Xyzal)

levocetirizine · UCB Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Levocetirizine (Xyzal), covering 2009-08-04 to 2009-08-04. Get the full timeline:

Most recent: Clinical Trial Update: Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464) [Phase 3]

See pricing